Alpha Crest Capital Management LLC 10x Genomics, Inc. Transaction History

Alpha Crest Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$28.48 - $52.59 $188,053 - $347,251	6,603 Added 96.09%	13,475 $384,000
Q2 2022 Aug 11, 2022	BUY	$36.95 - $82.41 $253,920 - $566,321	6,872 New	6,872 $311,000
Q1 2022 May 12, 2022	SELL	$55.7 - $145.79 $288,637 - $755,483	-5,182 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$135.05 - $182.59 $574,907 - $777,285	-4,257 Reduced 45.1%	5,182 $772,000
Q3 2021 Nov 10, 2021	BUY	$145.58 - $192.14 $1.07 Million - $1.41 Million	7,326 Added 346.71%	9,439 $1.37 Million
Q2 2021 Aug 12, 2021	BUY	$134.22 - $202.37 $283,606 - $427,607	2,113 New	2,113 $414,000
Q1 2021 May 13, 2021	SELL	$140.25 - $196.86 $350,625 - $492,150	-2,500 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$126.47 - $163.7 $316,175 - $409,250	2,500 New	2,500 $354,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.42B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.